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Infectious diseases exert a large and in many contexts growing burden on
human health, but violate most of the assumptions of classical epidemiolo-
gical statistics and hence require a mathematically sophisticated approach.
Viral shedding data are collected during human studies—either where vol-
unteers are infected with a disease or where existing cases are recruited—in
which the levels of live virus produced over time are measured. These have
traditionally been difficult to analyse due to strong, complex correlations
between parameters. Here, we show how a Bayesian approach to the inverse
problem together with modern Markov chain Monte Carlo algorithms
based on information geometry can overcome these difficulties and yield
insights into the disease dynamics of two of the most prevalent human
pathogens—influenza and norovirus—as well as Ebola virus disease.
1. Introduction
Infectious diseases continue to pose a major threat to human health, with
transmission dynamic models playing a key role in developing scientific under-
standing of their spread and informing public health policy [1]. These models
typically require many parameters to make accurate predictions, which interact
with data in complex, nonlinear ways. It is seldom possible to perform a series
of individual controlled experiments to calibrate these models, meaning that
the use of multiple datasets is often necessary [2].
At the population level, infectious disease models most frequently involve a
‘compartmental’ approach in which individuals progress between different dis-
crete disease states, usually at constant rates [3]. We note that alternatives to
such a compartmental approach exist, for example, use of a deterministic
time-varying infectivity, or allowing for non-Markovian state transitions in a
stochastic context [4]. There are theoretical differences between these and com-
partmental models for predictive epidemic modelling (see [5] for additional
discussion), but from the point of view of inference they pose very similar
challenges and therefore the rest of this paper will consider a compartmental
modelling framework.
At the individual level, there are three separate events that can be represented
using different compartments: (i) an individual receiving an infectious dose
of a pathogen, (ii) the individual becoming infectious and able to infect new
cases, and (iii) the individual ceasing to be infectious and becoming unable to
infect new cases. For some pathogens, there are also events relating to changes
in disease progression during the infectious period. The times elapsed between
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these events are important for understanding the epidemiol-
ogy of infectious diseases as well as designing control and
mitigation strategies [6,7].
Here, we consider how the rates of moving between com-
partments in standard epidemic models can be estimated
from shedding data generated either when individuals are
given an infectious dose of a virus under controlled conditions,
or when existing cases are enrolled in a study, and the level of
live virus that they produce (shed) is measured over time. The
nature of these models and data means that there are not
simple optimal values for the rate parameters, but instead the
data constrain the parameters to lie close to a nonlinear curve
in parameter space. We show that modern computationally
intensive Bayesian methods that make use of information
geometry can be used to calculate the posterior density
for models of influenza, norovirus and Ebola. We then use
forward modelling based on this posterior knowledge to
show that some epidemiological conclusions are robust
under the remaining uncertainty, but others require additional
information to determine. In particular, for influenza, we show
that the predicted effectiveness of quarantine-type inter-
ventions is unaffected by the remaining uncertainty, but
antiviral-like interventions have a bimodal uncertainty struc-
ture. For norovirus, we show that the frequency of epidemics
is predictable under the remaining uncertainty, but the severity
and timing of each seasonal epidemic is not. For Ebola, we are
able to distinguish between high- and low-viraemic infectious
disease progression, giving results that are consistent with
population-level observations of the case fatality ratio.
2. Methods
2.1. Overview
Our methodological approach involves three related com-
ponents. We start by defining the different compartmental
disease models that we use in §2.2. These are defined in terms
of each case’s natural history, which we represent mathematically
as a continuous-time Markov chain. We also show how these
models can be used to make population-level predictions by
assuming, for example, that an infectious individual will cause
new cases at a rate b.
Then in §2.3 we consider how the natural history parameters
can be estimated from shedding data. An important distinction
will be between the expected rate at which individuals infect in
the population (quantified using a rate like b above) and the
measured intensity of shedding (quantified using log titre). We
will generally assume a simple linear relationship between
these using a scaling parameter that we call t.
Finally in §2.4, we present the Bayesian approach to uncer-
tainty quantification as well as the algorithms necessary to
implement this for the complex posterior distributions that
arise in the analysis of shedding data.
2.2. Compartmental models of infectious disease
In a compartmental approach, we model the state of an individ-
ual who has been infected with a pathogen at time t ¼ 0 as an
integer random variable X(t). We label the possible states after
infection i,j, . . . [ f1, . . . ,mg; while more general structures are
needed for other pathogens, for both influenza and norovirus
we consider the ‘linear chain’ case where an individual spends
an exponentially distributed period of time with mean 1=gi in
each state i , m before progressing to state i þ 1, and where m
is the ‘recovered’ state, corresponding to the end of the infection,
from which the individual does not move. In the electronic
supplementary material, we provide a general solution for the
probability of being in disease compartment i at time t,
piðt; gÞ :¼ Pr½XðtÞ ¼ ijXð0Þ ¼ 1; g, ð2:1Þ
and its derivatives with respect to the rates fgig. For Ebola, we
consider a chain that branches, which introduces parameters
relating to the probability of following one path or another in
addition to rate constants.
We also assume that an individual has ‘infection rate’ li in
state i (with lm ¼ 0), which is proportional to the rate at which
they would infect new cases in a population-level epidemic
model. A key quantity is the expected infectiousness of an
individual over time
Lðt; uÞ :¼
Xm
i¼1
lipiðt; gÞ, ð2:2Þ
where the model parameters are u ¼ ðg,lÞ ¼ ðuaÞ. Perhaps the
most important quantity in any epidemiological model of infec-
tions is the basic reproductive ratio, R0, defined as the expected
number of secondary infections produced by a typical infectious
individual early in the epidemic [4]. Under the simplifying (but
frequently made) assumption of a homogeneous population,
this quantity is given by
R0ðuÞ ¼
ð1
t¼0
Lðt; uÞdt: ð2:3Þ
Note that the constants of proportionality l depend on
the nature and strength of interactions in the population
and therefore cannot be determined from measurements of
individuals alone.
2.2.1. The SIR model
One of the simplest models in mathematical epidemiology is
the SIR model, in which individuals are susceptible, infectious
or removed. We use this model as a simple example of the
methodology we propose. An individual infected at time t ¼ 0
spends an exponentially distributed period of time in the
infectious class, with rate g, before recovering, and has
infectiousness b. Therefore,
p1ðt; gÞ ¼ egt and Lðt; b,gÞ ¼ begt: ð2:4Þ
At the population level, supposing that we can ignore demo-
graphic processes such as births and deaths so the population
size is fixed at N, we have a set of ordinary differential equations
describing the evolution of an epidemic:
dS
dt
¼ b SI
N
,
dI
dt
¼ b SI
N
 gI and dR
dt
¼ gI: ð2:5Þ
Here S(t) is the expected number of susceptible individuals
in the population, I(t) is the expected number of infectious
cases and R(t) is the expected number of removed indivi-
duals; we will use a similar notation below generalized in a
natural way. In this work, we will consider how to fit
expressions such as (2.4) to shedding data in such a way that
population-level models such as (2.5) can be parametrized
accounting for uncertainty.
2.2.2. Influenza
Influenza is commonly modelled using the ‘SEEIIR’ or ‘SE2I2R’
framework, for example, in the work that was used to inform
vaccination policy during the recent H1N1 pandemic [8]. Here
m ¼ 5 and individuals spend a 2-Erlang distributed period of
time with mean 1/v in a non-infectious ‘exposed’ state, and
then a 2-Erlang distributed period of time with mean 1/g in
the infectious state, before recovering.
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To show the possible different impacts of uncertainty in par-
ameter values, we will consider two models for delayed
intervention (implemented after a time period of length d after
infection) during an influenza pandemic. The first of these
assumes that the intervention is ‘quarantine-like’ and completely
halts transmission after administration, leading to an epidemic
with reproduction number
Rð1Þd ¼
ðd
t¼0
Lðt; uÞdt: ð2:6Þ
The second, however, assumes that the individual must not have
progressed from the ‘latent’ to the ‘infectious’ class and is there-
fore similar to some models of administration of antiviral
medication like Tamiflu [9,10], leading to an epidemic with
reproduction number
Rð2Þd ¼ ð1 Pr½XðdÞ , 3ÞR0: ð2:7Þ
We note from standard results in mathematical epidemiology
[4] that if the infection rate is b, and the mean infectious period is
1/g, then the basic reproductive ratio is R0 ¼ b/g, and for an epi-
demic with reproduction number R the epidemic final size Z is
given by the solution to the transcendental equation
Z ¼ 1 eRZ, ð2:8Þ
which we solve numerically for the two different reproduction
numbers Rð1Þd and R
ð2Þ
d above, a range of delays, and fitted
values of the parameters (v, g) at a fixed value of R0 ¼ 1.4 (as
in [8]) to make a direct comparison, although it would be
straightforward to place a distribution on R0. We note that
while all parameter values agree on the value of
R0 ¼ limd!1 Rd, and that limd!0 Rd ¼ 0, at finite non-zero d the
uncertainty in parameters will lead to posterior variability in
Rd and hence Z.
Temporal features of an influenza epidemic are often more
relevant for policy than the final size [11,12] and are typically
considered using systems of differential equations. As we are
considering an intervention with fixed delay, we couple the stan-
dard ODE system [8] to a set of terms modelling the delayed
intervention leading to the delay-differential equation system
dS
dt
¼  b
N
SðtÞIðtÞ,
dE1
dt
¼ b
N
SðtÞIðtÞ  2vE1ðtÞ  p1ðd; v, gÞ bN Sðt dÞIðt dÞ,
dE2
dt
¼ 2vðE1ðtÞ  E2ðtÞÞ  p2ðd; v, gÞ bN Sðt dÞIðt dÞ,
dI1
dt
¼ 2ðvE2ðtÞ  gI1ðtÞÞ  ep3ðd; v, gÞ bN Sðt dÞIðt dÞ
and
dI2
dt
¼ 2gðI1ðtÞ  I2ðtÞÞ  ep4ðd; v,gÞ bN Sðt dÞIðt dÞ,
9>>>>>>>>=
>>>>>>>>;
ð2:9Þ
where the variable e is 1 if the intervention works for any
infected individual and 0 if it only works during the latent
period, and d is the intervention delay. piðt; v,gÞ is the prob-
ability of being in state i time t after starting in state 1 at time 0
as in (2.1) above and is also determined by the parameters in
the shedding model.
2.2.3. Norovirus
Norovirus is usually assumed to follow the ‘SEIRS’ framework
[13], where after infection an individual spends an exponentially
distributed period of time with mean 1/v in a ‘latent’ class, then
an exponentially distributed period of time with mean 1/g in the
infectious class. In contrast to influenza, individuals move from
the ‘recovered’ class back to the ‘susceptible’ class with rate m;
this loss of immunity is a relatively slow process that does not
impact on the analysis of shedding data. It does, however,
influence the population-level disease dynamics of norovirus,
which can be described using a set of ordinary differential
equations, where S(t) stands for the expected number of people
who are susceptible and similarly for other compartments:
dS
dt
¼dNþmRbðtÞSI
N
dS, dE
dt
¼bðtÞSI
N
vEdE,
dI
dt
¼vEgIdI and dR
dt
¼gImRdR:
9>=
>; ð2:10Þ
Here we have assumed a constant effective population size N and
have a time-varying infection rate (which is necessary to repro-
duce the regular seasonality seen in real data [13]) that we
assume takes a sinusoidal form bðtÞ¼b0ð1þAsinðatÞÞ. Because
such external forcing in transmission is typically believed to
arise from school terms [14], we take A ¼ 1/3 to be close to exist-
ing empirical estimates of the impact of school closures on
disease spreading [15,16], and a can be set to 2pyr1. The demo-
graphic rate d is standardly set to 1/70 yr–1. From the results of
[17], we have that R0¼b0=g; we vary this and the rate of waning
immunity m within ranges suggested by Simmons et al. [13], and
then run the model (2.10) to determine its long-term behaviour
for different fitted values of the parameters (v, g).
A norovirus vaccine is likely to be available in the future [18],
and we model the impact of a vaccination policy starting at time
u and with effective coverage v (defined as the product of cover-
age and efficacy) by modification of the demographic term for S
and addition of a vaccinated V compartment:
dS
dt
¼ dð1 vQðt uÞÞN þ mR bðtÞ SI
N
 dS
and
dV
dt
¼ dðvQðt uÞN  VÞ:
9>=
>; ð2:11Þ
Here Q is the step function, leaving us with a set of time-
inhomogeneous ordinary differential equations.
2.2.4. Ebola
Ebola is both much less common than influenza and norovirus
and much more dangerous. This means that the modelling fra-
mework for it is less established—although it is typically
assumed to follow an SEIR-type framework [19,20]—and also
that challenge studies cannot be performed. Instead, existing
cases are recruited and their viral loads are monitored. Our mod-
elling approach is based on the results of such studies [21]. This is
shown diagrammatically in figure 1 and is described by
equations
dJ1
dt
¼ u1J1, dJ2dt ¼ u1J1  u1J2,
dI1
dt
¼ u2u1J2  u3I1, dI2dt ¼ u3I1  u3I2,
dH1
dt
¼ ð1 u2Þu1J2  u4H1, dH2dt ¼ u4H1  u4H2,
dR
dt
¼ u3I2 and dDdt ¼ u4H2:
9>>>>>>=
>>>>>>;
ð2:12Þ
In this study design, the latent E states are not observed and so
the initial condition is J1ð0Þ ¼ 1 with all other quantities initially
0. Parameter interpretations and priors are given in table 1.
The transmission rates for low- and high-viraemic pathways
are, respectively,
Ll ¼ bðu5(J1 þ J2)þ u6ðI1 þ I2ÞÞ
and Lh ¼ bðu5(J1 þ J2)þ u7ðH1 þH2ÞÞ:
)
ð2:13Þ
2.3. Shedding model and data
Our aim is to extract parameter estimates for compartmental epi-
demic models from challenge studies in which human volunteers
are infected with a pathogen, or observational studies based on
rsif.royalsocietypublishing.org
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existing cases, and the level of live virus they produce (or ‘shed’)
is measured over time. The concentration of live virus is quanti-
fied as a ‘titre’, which is essentially an estimate of the
concentration of live virus. The relationship between this quan-
tity and transmissibility is complex, but generally agreed to be
sub-linear [22,23]. We assume here that at each time point t the
log titre y is proportional to the expected intensity of infection
L(t) plus additive Gaussian noise representing experimental
error and other factors such as individual-level variability, lead-
ing to likelihood functions based on products of normal
distribution probability mass functions. The details are, however,
different for the four scenarios we consider and so we define our
models separately below.
2.3.1. The SIR model
For the SIR model, we assume one observation y of shedding
with standard deviation s at time t leading to likelihood function
Lðyjt, gÞ ¼ N ðyjteg; sÞ: ð2:14Þ
We will use this as a toy model to demonstrate our methodologi-
cal approach, using numerical values y ¼ 1, s ¼ 0.02 and t ¼ 1.
Note that here and throughout, we write the probability density
function for the normal distribution with mean m and standard
deviation s evaluated at x as
N ðxjm; sÞ ¼ 1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2s2p
p exp ðx mÞ
2
2s2
 !
: ð2:15Þ
2.3.2. Influenza
For influenza, we use the meta-analysis data of Carrat et al. [24]
for viral titre in the nasal passages of individuals infected with
influenza A H1N1, which is shown in figure 2a. Here, obser-
vations are made at regularly spaced times belonging to a
set T . Under our general modelling assumptions, the likelihood
of observing a set of mean log-titres (yt) among participants,
with associated standard deviations (st), given the model
parameters, is
Lðy,sjuÞ ¼
Y
t[T
N ðyt; ðt=bÞLðtjuÞ,stÞ, ð2:16Þ
where N is the normal distribution probability density function
intended to capture various sources of experimental error and
individual-level variability as would be expected due to the cen-
tral limit theorem. Here, we assume that the variance at each time
point is measured, as given in [24]. Because the infection rate b
depends inter alia on the rate of contact between individuals,
which cannot be estimated from shedding data, we rescale the
infectiousness L using the scaling parameter t meaning that
our parameters for estimation are u ¼ ðt,v, gÞ.
2.3.3. Norovirus
For norovirus, we use data from the study of Atmar et al. [25],
where individuals were infected under controlled conditions
and observations of viral titre in faeces made irregularly at
times belonging to a set T : These data are shown in figure 3a
and since they do not aggregate in the same way as the influenza
data the likelihood function is
Lðyju,sÞ ¼
Y
t[T
N yt; t
b
 
LðtjuÞ,s
 
, ð2:17Þ
so s is here an additional parameter that must be estimated, and
we have rescaled the infectiousness as before using t. This makes
the norovirus parameter space dimension 4, in contrast to dimen-
sion 3 for influenza, with u ¼ ðt,v,g,sÞ.
2.3.4. Ebola
For Ebola, we use the data of Ksiazek et al. [21] on viral titre in
the blood of hospitalized Ebola cases, which are stratified into
low- and high-viraemic disease pathways as shown in figure 1,
together with the model described by equations (2.12). This
leads to a likelihood function that takes the form of a product
of low and high trajectories, each of which is similar to the
influenza likelihood:
Lðy,sjuÞ ¼
Y
t[T l
N yl,t;
1
b
 
LlðtjuÞ,sl,t
 

Y
t[T h
N yh,t; 1
b
 
LhðtjuÞ,sh,t
 
, ð2:18Þ
where we use a natural subscripting of ‘l’ for low and ‘h’ for high,
and the parameters for estimation are ðu1, . . . ,u7Þ as shown
in table 1.
2.4. Statistical framework
2.4.1. The Bayesian approach to identifiability
It is long-established that fitting of a sum of exponentials to
data is potentially troublesome; in particular, Acton [26]
high
viraemia
initial
viraemia
J1 J2
H1 H2
D
I1 I2 Rq3q3
q1 q2 q4
q5
q7
q4
q6
q1
q1(1 – q2)
low
viraemia recovery
death
Figure 1. Ebola model compartmental structure and role of parameters.
Compartments are shown as circles; flows between compartments are
shown as thin black arrows labelled with parameters; and infectiousness is
indicated by outward facing block arrows labelled with parameters.
Table 1. Parameters of the Ebola model, their interpretation and prior
distribution.
parameter interpretation prior
u1 2/(mean time in initial
viraemic state)
Exp(0.01)
u2 proportion entering high-
viraemic state
Uniform([0,1])
u3 2/(mean time in low-viraemic
state)
Exp(0.01)
u4 2/(mean time in high-
viraemic state)
Exp(0.01)
u5 scaling parameter for initial
viraemic state
Exp(0.1)
u6 scaling parameter for low-
viraemic state
Exp(0.1)
u7 scaling parameter for high-
viraemic state
Exp(0.1)
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considers fitting the model y ¼ Aeat þ Bebt to (y, t) pairs and
notes that ‘there are many combinations of (a, b,A, B) that
will fit most exact data quite well indeed [. . .] and when exper-
imental noise is thrown into the pot, the entire operation
becomes hopeless’.
Our compartmental models are more complex than sums of
exponentials, but exhibit the same lack of a clear mode in the
likelihood function. While there are various methods to address
this issue in other applications (e.g. [27]), another response is
(informally speaking) to consider all parameter combinations
that fit well, and to investigate the epidemiological consequences
of this uncertainty in parameter values.
More formally, we work in a Bayesian framework, meaning
that we attempt to calculate the posterior density p over par-
ameters u from the likelihood function L and the prior function
f using Bayes’ rule
pðujyÞ ¼ LðyjuÞf ðuÞÐ
LðyjqÞf ðqÞdq : ð2:19Þ
Given fixed data y, the measure pðujyÞdu is higher in more cred-
ible regions of parameter space, and can be multi-modal and/or
with many combinations of parameters having the same level of
posterior support.
Here, we attempt to use priors that are broadly speaking
uninformative—either uniform or improper if there is sufficient
data, or low-rate exponential if there is less data. It is important
to note, however, that use of strongly informative priors is
another method for restoration of identifiability, in the sense of
an approximately multivariate normal posterior distribution
that is concentrated in the region of a unique mode.
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Figure 2. Analysis of influenza shedding data. (a) Data and empirical confidence intervals (black) against model mean and 95% credible interval (red). (b) Posterior
samples obtained using WHLMC. (c) Diagonal plots: marginal posterior density estimates for each parameter. Bottom left plots: marginal log posterior for pairs of
parameters—first-order gradients will be perpendicular to contours. Top right plots: samples (black) with visualizations of the metric—based on expectations of
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2.4.2. Markov chain Monte Carlo
Typically, the integral in the denominator of (2.19) is not tractable
so we adopt the popular methodology of defining a Markov
chain on parameter space whose stationary distribution has
probability density function p, i.e. Markov chain Monte Carlo
(MCMC) [28,29], in particular the Metropolis–Hastings algor-
ithm [30,31]. This is a discrete-time Markov chain in which a
change of state from u n to u  is proposed with probability
qðu ju nÞ and the proposal is accepted with probability
a ¼ 1 ^ Lðyju
Þfðu Þqðu nju Þ
Lðyju nÞfðu nÞqðu ju nÞ : ð2:20Þ
We shall now outline five popular approaches to MCMC, three
that do not make use of derivatives and two that do, with all
being in some sense a special case of (2.20).
2.4.3. Derivative-free Markov chain Monte Carlo algorithms
(i) Independence sampling. In independence sampling, there is no
dependence on the current state for the proposal distribution.
A popular choice is simply to sample from the prior so that
qðu0juÞ ¼ fðu0Þ: ð2:21Þ
Intuitively, such an approach is expected to work well when the
posterior is ‘close’ to the prior.
(ii) Random walk. In a random walk approach, the current state of
the Markov chain is only used to inform the mean of the propo-
sal distribution. The most popular choice is the multivariate
normal
qðu0juÞ ¼ N ðu0ju,SÞ, ð2:22Þ
where the constant matrix S is often adaptively tuned to
optimize algorithmic performance [32].
(iii) Gibbs. If it is possible to sample from the marginal posterior
for a parameter ua then we can propose with density
qðu0juÞ ¼ pðu0aju1, . . . ,ua1,uaþ1, . . . ,un,yÞ: ð2:23Þ
From (2.19) and (2.20), we then see that the acceptance prob-
ability for such a proposal is 1. If the marginal posteriors for
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all parameters are known, then pure Gibbs sampling can be
undertaken and involves cycling through proposals (2.23) for
all a.
2.4.4. Derivative-based Markov chain Monte Carlo
In the field of numerical optimization, methods such as gradient
descent that make use of the first-order derivatives of the func-
tion to be optimized are popular. Significant care must be
taken when extending these to stochastic algorithms such as
MCMC, but there are two popular methods that make use of
the first-order derivatives of L :¼ lnðLfÞ. We use the following
notation:
@aL :¼ @L
@ua
and @L ¼ ð@aLÞ; ð2:24Þ
note that throughout we write (xi) for the vector x with ith
element xi and (Mij) for the matrix M with (i, j )th element Mij.
There are then two main families of derivative-based MCMC
algorithms that we consider.
(i) MALA. The first algorithm family starts with the Langevin
equation
du ¼ 12@Ldtþ dW: ð2:25Þ
This stochastic differential equation model has a stationary distri-
bution equal to the posterior distribution as defined in (2.19), and
the Metropolis-adjusted Langevin algorithm (MALA) uses the
Euler approximation to (2.25):
Du  1
2
@Leþ e1=2U N e
2
 
@L, eI
 
, ð2:26Þ
where U is a vector of independent standard normal random
variables and I is the identity matrix. The approximation (2.26)
can then be used as a proposal within the Metropolis–Hastings
algorithm [33].
(ii) HMC. The second family of algorithms starts from the follow-
ing system of ordinary differential equations that are a special
case of Hamiltonian dynamics:
du
dt
¼ v and dv
dt
¼ @L: ð2:27Þ
The randomness in the proposals arises as a result of the starting
value of a vector of auxiliary variables v, by default chosen as a
vector of standard normal random variables. MCMC algorithms
based on Hamilton’s equations (2.27) are called hybrid [34] or
Hamiltonian [35] Monte Carlo (HMC).
One important thing to note about these algorithms is that
they use likelihood derivatives to improve acceptance rates,
but since they include a Metropolis–Hastings step the derivative
calculations could be approximate.
2.4.5. Geometric concepts in Markov chain Monte Carlo
While both MALA and HMC remove some of the inefficiencies
of random walks through use of local gradients, they are not par-
ticularly efficient for the curved ‘boomerang’-shaped posteriors
that we see for the shedding models and data defined above.
To address this issue, recent work has made progress through
use of concepts from differential geometry [36].
In general, we have n real-valued parameters, where the
support for the posterior distribution is a set P # Rn. A general
vector of parameter values is u ¼ ðu1, . . . ,unÞ [ P, and informally
speaking a metric is defined as a smooth symmetric map
s :P P ! ½0,1Þ such that sðu, u0Þ is the ‘distance’ between u
and u. In practice, we will only need to define this over small
local distances, which requires a metric matrix GðuÞ ¼ ðGabÞ;
explicitly, the infinitesimal distance between u and u þ du is
dsðu, duÞ ¼
X
a,b
Gabduadub
 !1=2
: ð2:28Þ
Here G can be any smooth matrix function and conceptually
speaking this means that even the most complex posterior can
be efficiently sampled with a choice of metric that brings all
high-density regions of parameter space sufficiently ‘close’ to
each other.
Throughout this work, we will visualize the impact of the
metric in the plane for two parameters of a general model
using ellipses, which are defined as follows. Let Gðu1, . . . ,unÞ
be the metric matrix and consider the first two parameters
ðu1,u2Þ without loss of generality. Now let
ðGðu1,u2,u^3, . . . ,u^nÞÞab ¼ ðGabÞ, a, b [ f1, 2g, ð2:29Þ
where u^i is a point estimate (we choose the posterior median) for
the parameter ui. Consider the ellipse defined by the following
equation for polar coordinates distance r (from ðu1,u2Þ in the
plane) and angle a:
rðaÞ ¼ (G11 cos2ðaÞ þ G12 cosðaÞ sinðaÞ þ G21 sinðaÞ cosðaÞ
þG22 sin2ðaÞ)1=2: ð2:30Þ
Plotting several such ellipses in the plane allows us to visualize
the impact of the metric in the following sense: points on each
ellipse are all the same ‘distance’ from the centre as each other
under the assumption of a locally constant metric.
While it is not simple to optimize the metric for a particular
model, a generally well-motivated choice is the Fisher–Rao
metric as suggested by Girolami & Calderhead [36]
GabðuÞ ¼ E½@aL@bL, ð2:31Þ
where the expectation is taken over data. Benefits of this metric
include that it ensures the matrix G will be positive definite,
and hence that the inverse matrix G21 will exist and be positive
definite. Calculations of the Fisher–Rao metric for the models
under consideration are given in the electronic supplementary
material, showing that it is also available in a closed form for
our models. We note that other metrics are sometimes preferable,
as discussed by, for example, Betancourt [37]; however in our
case the Fisher–Rao metric proved to be adequate.
We used two different geometric algorithms, chosen based
on features of the posterior.
(i) SMMALA. The simplified manifold Metropolis-adjusted
Langevin algorithm (SMMALA) was introduced in [36] and
shown to be competitive in terms of computational effort in sev-
eral applied contexts by Calderhead and co-workers [38,39]. In
this approach, the proposal distribution is
qðujunÞ ¼ N u; un þ e
2
 
G1@L, eG1
 
, ð2:32Þ
with standard MALA recovered if we set G ¼ I. Note that the
inverse of the metric matrix is used to ensure that the expected
distance (as defined in (2.28)) of a move is directionally invariant.
We used SMMALA to sample from the norovirus and Ebola pos-
teriors, which each had one mode but were strongly correlated
with variable local correlation structure.
(ii) WHLMC. The idea behind wormhole Lagrangian Monte
Carlo (WHLMC) is that for a multi-modal posterior, a metric
can be defined that dramatically reduces the distance between
modes, and a modified form of the dynamics (2.27) can exploit
this proximity. Full details of the algorithm are highly technical
and are given in the papers that first introduced it [40,41], as
well as in our electronic supplementary material.
3. Results
3.1. Selection of Markov chain Monte Carlo algorithm
Taking the simple likelihood function (2.14) together with
prior distribution uniform ([0, 5]  [0, 3]) we were able to
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run the full set of MCMC algorithms discussed above to
assess their efficiency. Figure 4 shows the results of running
these algorithms.
In terms of the derivative-free algorithms, the low-
dimensional nature of the problem means that the
independence sampler does relatively well. Both of the
random walk and Gibbs samplers are not able to move
efficiently through the region of high posterior density due
to its narrow, curved structure. By contrast, SMMALA is
able to adjust to variations in local posterior structure and
as such provides a series of samples from the posterior that
are much more independent of each other than other
approaches. This is explained by figure 4e,f that visualize
the impact of the geometry in this algorithm.
Figures 2, 3 and 5 also show that the Fisher–Rao metric
and associated geometry generally correctly resolves the dif-
ficulties associated with our highly correlated posterior
distributions for influenza, norovirus and Ebola, allowing
accurate quantification of uncertainty in epidemiological
rates. The question then becomes under what circumstances
the additional computational effort of implementation of
these algorithms is warranted, which has no simple answer
here as in other areas of computational statistics; however,
we note the following points.
First, standard measures of performance such as mini-
mum effective sample size per CPU second [36] often
overstate the effectiveness of inaccurate algorithms for our
models. Figure 4b shows that over iterations 2–3000,
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random walk sampling appears to be well-behaved and
would yield a high ESS despite only being in a small sub-
area of the region of parameter space from which we
would like to sample.
Secondly, if the posterior density is concentrated in a
nonlinear region, derivative-free methods such as Gibbs, inde-
pendence sampling and random walk will have a general
tendency to get ‘stuck’ in sub-areas. This will not be proble-
matic if there are sufficient computational resources available
to perform significant thinning—i.e. removal of MCMC
samples to reduce correlations between those that remain.
Thirdly, computational resources for these algorithms
will almost certainly become overstretched in any of the fol-
lowing three limits: (i) As the dimensionality of parameter
space becomes larger, for example, in our Ebola model.
(ii) In the presence of multi-modality as in our influenza
model. (iii) For extreme cases of unidentifiability, for
example, the s! 0 limit of our SIR model.
Finally, the geometric methods for MCMC that we pre-
sent and employ here are designed to be particularly
well suited to complex nonlinear relationships between
parameters where the derivatives of the log-likelihood and
log-prior are available in an analytically closed form, which
is the case for our models. Despite this we note that there
are many other sophisticated approaches to computationally
intensive Bayesian inference [29] that could be of use due
to their generality.
3.2. Influenza parameters and antiviral treatment
Figure 2 shows the results for our influenza model given
rate-0.1 exponential priors on each parameter (chosen not to
influence the posterior significantly but to ensure that the
small number of data points does not become problematic).
This shows that the credible ranges of individual parameters
are close to typical values in the literature—Baguelin et al. [8],
for example, consider scenarios with v [ ½0:5, 10 and
g [ ½0:5, 2:5.
More importantly, however, the bimodal and highly corre-
lated nature of the posterior distribution means that for some
models of antiviral action it is not possible to make firm pre-
dictions based on parameter values from challenge studies.
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Figure 6a,c,e shows the results of a quarantine-like intervention
that is always effective after a delay, where the relationship
between delay in antiviral administration and epidemic final
size at constant R0 is predictable to within a few percentage
points, although there is much greater uncertainty in the
peak prevalence. Figure 6b,d,f shows an antiviral-like interven-
tion that is only effective if administered during the latent
period, meaning the absolute uncertainty in final size can be
almost 50% and the relative uncertainty in peak prevalence
can amount to a factor of four or more.
3.3. Norovirus parameters and seasonality
Figure 3 shows the results for our norovirus model; given the
large amount of data we use improper priors and see that the
credible ranges of individual norovirus parameters are also
close to typical values in the literature; e.g. Simmons et al.
[13] take v ¼ 1 and g ¼ 0.5.
Figure 7 shows that the impact of this uncertainty (for
other parameter values as given above) is mainly seen in the
height (with peak prevalence differing by a factor of 3 or
more) and timing within the year of seasonal epidemics. For
the chaotic/irregular scenario (figure 7b) however, the overall
epidemic dynamics are subject to significant uncertainty. For-
tunately, conditioned on knowing that epidemics are regular
and annual and with a particular peak, the broad impact of
a vaccine policy can be predicted as shown in figure 7e.
3.4. Ebola parameters and case fatality ratio
Figure 5 shows the results obtained for our Ebola model. The
point estimates and 95% CIs of mean infections period come
out at 5.3[3.3, 7.4] days for low-viraemia cases and 6.8[5.1,
10.1] days for high-viraemia cases, which are reasonable
values [20]. Figure 5a shows that the model produces shed-
ding output that is consistent with the data, and figure 5b
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compares the posterior for the case fatality ratio obtained
from shedding data to the one obtained from known out-
comes of previous outbreaks [42], again suggesting that the
model outcome is reasonable but that uncertainties are
very large.
4. Discussion
In summary, we have shown that it is possible to use
modern Bayesian MCMC methods, based on derivatives of
the log-likelihood and information geometry, to make a full
uncertainty quantification of epidemiological parameters
fitted to human viral shedding data. We have performed
our analysis for two of the most prevalent pathogens: influ-
enza and norovirus, as well as for Ebola, a highly virulent
zoonotic disease.
Shedding data allow disease ‘natural history’ parameters
to be fitted; these usually need to be combined with popu-
lation-level measurements such as the basic reproductive
ratio R0 to specify policy-relevant models fully. Our results
show that the epidemiological consequences of uncertainty
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in natural history parameters can often be highly significant
since these are important for interventions such as reducing
transmission through quarantine or medication, as well as
prediction of long-term disease behaviour and clinical out-
comes. Natural history parameters also strongly affect other
aspects of infectious disease epidemiology such as outbreak
reconstruction and we would expect similarly strong effects
in these contexts.
To make progress, we have had to base our analysis on
simplifying assumptions that we would hope can be relaxed
in future work as the field develops. One example is that the
simple likelihood functions (2.18) and (2.17) assume indepen-
dence that could be extended to include more general
functional relationships, which would be particularly impor-
tant if the methodology were extended to diseases such as
human immunodeficiency virus where there are very differ-
ent time scales involved in passing between compartments
[43]. In such an example, one might wish to consider more
general models, for example, ones in which the progression
between the latent, infectious and removed classes is gov-
erned by more general distributions than those we have
considered here. Provided the Laplace transformations of
the probability density functions for these distributions are
available, then expressions for L and its derivatives with
respect to the parameters can be obtained via the convolution
theorem, although this can result in a computationally inten-
sive likelihood function. Alternatively, it might be possible to
approximate the derivatives since inaccuracies in any such
approximation will lead to algorithmic inefficiency rather
than bias.
An additional assumption we have made is that the
parameters we are not fitting (for example, the basic repro-
ductive ratio R0) are fixed. This is particularly important to
relax if multiple data sources are to be used in a principled
way in infectious disease modelling for public health [2]. In
particular, the measurements at the population level required
to estimate R0 are likely to carry their own uncertainty, which
can be combined with our uncertainty quantification for dis-
ease natural history parameters as the next step towards
systematic evidence synthesis for infectious diseases.
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